Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand

A Multicenter, Eight-Week Treatment, Single-Step Titration, Open-Label Study Assessing The Percentage Of Dyslipidemic Patients Achieving LDL Cholesterol Target With Atorvastatin Starting Doses Of 10 Mg, 20 Mg, And 40 Mg

The purpose of this study is to evaluate the efficacy of atorvastatin in lowering cholesterol on patients from Thailand with high cholesterol.

Inclusion Criteria:

• Dyslipidemic patients who were eligible for lipid lowering therapy
• Willingness to follow study diet for 1 month prior to screening and for the duration of the study

Exclusion Criteria:

• Use of other lipid lowering agents (6-week washout period)
• Uncontrolled high blood pressure
• Impaired liver function